OPV
Sponsors
Bandim Health Project, GlaxoSmithKline, Merck Sharp & Dohme LLC, Universiteit Antwerpen, Centers for Disease Control and Prevention, China
Conditions
Acellular PertussisDiphtheriaGrowthHaemophilus Influenzae Type bHepatitis BMalariaMorbidityMortality
Phase 2
Phase 3
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine
CompletedNCT01457560
Start: 2000-02-29End: 2001-04-30Updated: 2016-08-05
Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)
CompletedNCT02062385
Start: 2014-05-30End: 2015-06-11Updated: 2018-11-27